First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock

Kevin Travers41minutes ago

Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure

BenzingaJan 10 08:35 ET

Pfizer's Bladder Cancer Treatment Achieves Main Goal in Late-stage Trial

Seeking AlphaJan 10 07:47 ET

Express News | Arvinas: Vepdegestrant to Be Combined With Pfizer's Cdk4 Inhibitor Atirmociclib in a First-Line Phase 3 Trial Planned to Initiate in 2025

ReutersJan 10 07:01 ET

Pfizer Announces 'Positive' Results From Phase 3 CREST Trial of Sasanlimab

TipRanksJan 10 06:56 ET

Pfizer's Sasanlimab in Combination With BCG Improves Event-Free Survival in Patients With BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

BusinesswireJan 10 06:45 ET